Ibnova Therapeutics ApS

Private limited companyCVR 46238656København NActive

Ibnova Therapeutics ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2026. The company is new and has been registered for less than a year. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

What has changed

calculated from recorded figures and dates

Management and owners, last 24 months

  • New in management: Andrew Laskary (director, 06/02/2026) and Andrew Laskary (chair of the board, 06/02/2026).
  • New owners registered: Andrew Laskary (06/02/2026), Enzo Roberto Porrello (06/02/2026) and James Edward Hudson (06/02/2026).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Ibnova Therapeutics ApS–
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Ibnova Therapeutics ApS–
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Ibnova Therapeutics ApS–
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Ibnova Therapeutics ApS2
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Andrew Laskary33.33%
  • Enzo Roberto Porrello25%
  • James Edward Hudson25%
Ibnova Therapeutics ApS

Management

2 active registrations

Executive management

Executive management at Ibnova Therapeutics ApS
NameRoleAppointed
Andrew LaskaryDirector06/02/2026

Board of directors

Board of directors at Ibnova Therapeutics ApS
NameRoleAppointed
Andrew LaskaryChair of the board06/02/2026
Founders
Andrew Laskary, Enzo Roberto Porrello, James Edward Hudson

Signing rule: Selskabet tegnes af en direktør eller et bestyrelsesmedlem.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

  • BII Holdings A/SOther financial service activities n.e.c.
  • Skape Bio ApSResearch and experimental development on natural sciences and engineering
  • Agrobiomics ApSResearch and experimental development on natural sciences and engineering
  • Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
  • BioColor ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Ibnova Therapeutics ApSOle Maaløes Vej 3, 2200 København N31032110777

Purpose

Selskabets formål er at forske i, udvikle, fremstille og kommercialisere therapeutiske produkter og beslægtede løsninger inden for life sciences og sundhed.

The purpose is quoted from the register in Danish.

Changes year by year

6 registered events
20266 changesfounded 1 · management 2 · ownership 3
  • Registered as Ibnova Therapeutics ApS
  • Andrew Laskary appointed director
  • Andrew Laskary appointed chair of the board
  • Andrew Laskary registered as owner (33.33%)
  • Enzo Roberto Porrello registered as owner (25%)
  • James Edward Hudson registered as owner (25%)

Related companies

Same industry in København

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction